Global Etanercept Market Research Report 2019
Table of Contents
Executive Summary
1 Etanercept Market Overview
- 1.1 Product Overview and Scope of Etanercept
- 1.2 Etanercept Segment by Type
- 1.2.1 Global Etanercept Production Growth Rate Comparison by Type (2014-2025)
- 1.2.2 Benepali
- 1.2.3 Enbrel
- 1.2.4 Others
- 1.3 Etanercept Segment by Application
- 1.3.1 Etanercept Consumption Comparison by Application (2014-2025)
- 1.3.2 Arthritis
- 1.3.3 Psoriasis
- 1.3.4 Spondylitis
- 1.4 Global Etanercept Market by Region
- 1.4.1 Global Etanercept Market Size Region
- 1.4.2 North America Status and Prospect (2014-2025)
- 1.4.3 Europe Status and Prospect (2014-2025)
- 1.4.4 China Status and Prospect (2014-2025)
- 1.4.5 Japan Status and Prospect (2014-2025)
- 1.5 Global Etanercept Market Size
- 1.5.1 Global Etanercept Revenue (2014-2025)
- 1.5.2 Global Etanercept Production (2014-2025)
2 Global Etanercept Market Competition by Manufacturers
- 2.1 Global Etanercept Production Market Share by Manufacturers (2014-2019)
- 2.2 Global Etanercept Revenue Share by Manufacturers (2014-2019)
- 2.3 Global Etanercept Average Price by Manufacturers (2014-2019)
- 2.4 Manufacturers Etanercept Production Sites, Area Served, Product Types
- 2.5 Etanercept Market Competitive Situation and Trends
- 2.5.1 Etanercept Market Concentration Rate
- 2.5.2 Etanercept Market Share of Top 3 and Top 5 Manufacturers
- 2.5.3 Mergers & Acquisitions, Expansion
3 Global Etanercept Production Market Share by Regions
- 3.1 Global Etanercept Production Market Share by Regions
- 3.2 Global Etanercept Revenue Market Share by Regions (2014-2019)
- 3.3 Global Etanercept Production, Revenue, Price and Gross Margin (2014-2019)
- 3.4 North America Etanercept Production
- 3.4.1 North America Etanercept Production Growth Rate (2014-2019)
- 3.4.2 North America Etanercept Production, Revenue, Price and Gross Margin (2014-2019)
- 3.5 Europe Etanercept Production
- 3.5.1 Europe Etanercept Production Growth Rate (2014-2019)
- 3.5.2 Europe Etanercept Production, Revenue, Price and Gross Margin (2014-2019)
- 3.6 China Etanercept Production (2014-2019)
- 3.6.1 China Etanercept Production Growth Rate (2014-2019)
- 3.6.2 China Etanercept Production, Revenue, Price and Gross Margin (2014-2019)
- 3.7 Japan Etanercept Production (2014-2019)
- 3.7.1 Japan Etanercept Production Growth Rate (2014-2019)
- 3.7.2 Japan Etanercept Production, Revenue, Price and Gross Margin (2014-2019)
4 Global Etanercept Consumption by Regions
- 4.1 Global Etanercept Consumption by Regions
- 4.2 North America Etanercept Consumption (2014-2019)
- 4.3 Europe Etanercept Consumption (2014-2019)
- 4.4 China Etanercept Consumption (2014-2019)
- 4.5 Japan Etanercept Consumption (2014-2019)
5 Global Etanercept Production, Revenue, Price Trend by Type
- 5.1 Global Etanercept Production Market Share by Type (2014-2019)
- 5.2 Global Etanercept Revenue Market Share by Type (2014-2019)
- 5.3 Global Etanercept Price by Type (2014-2019)
- 5.4 Global Etanercept Production Growth by Type (2014-2019)
6 Global Etanercept Market Analysis by Applications
- 6.1 Global Etanercept Consumption Market Share by Application (2014-2019)
- 6.2 Global Etanercept Consumption Growth Rate by Application (2014-2019)
7 Company Profiles and Key Figures in Etanercept Business
- 7.1 Pfizer
- 7.1.1 Pfizer Etanercept Production Sites and Area Served
- 7.1.2 Etanercept Product Introduction, Application and Specification
- 7.1.3 Pfizer Etanercept Production, Revenue, Price and Gross Margin (2014-2019)
- 7.1.4 Main Business and Markets Served
- 7.2 Takeda
- 7.2.1 Takeda Etanercept Production Sites and Area Served
- 7.2.2 Etanercept Product Introduction, Application and Specification
- 7.2.3 Takeda Etanercept Production, Revenue, Price and Gross Margin (2014-2019)
- 7.2.4 Main Business and Markets Served
- 7.3 Johnson & Johnson
- 7.3.1 Johnson & Johnson Etanercept Production Sites and Area Served
- 7.3.2 Etanercept Product Introduction, Application and Specification
- 7.3.3 Johnson & Johnson Etanercept Production, Revenue, Price and Gross Margin (2014-2019)
- 7.3.4 Main Business and Markets Served
- 7.4 GlaxoSmithKline
- 7.4.1 GlaxoSmithKline Etanercept Production Sites and Area Served
- 7.4.2 Etanercept Product Introduction, Application and Specification
- 7.4.3 GlaxoSmithKline Etanercept Production, Revenue, Price and Gross Margin (2014-2019)
- 7.4.4 Main Business and Markets Served
- 7.5 Samsung Bioepis
- 7.5.1 Samsung Bioepis Etanercept Production Sites and Area Served
- 7.5.2 Etanercept Product Introduction, Application and Specification
- 7.5.3 Samsung Bioepis Etanercept Production, Revenue, Price and Gross Margin (2014-2019)
- 7.5.4 Main Business and Markets Served
- 7.6 Roche
- 7.6.1 Roche Etanercept Production Sites and Area Served
- 7.6.2 Etanercept Product Introduction, Application and Specification
- 7.6.3 Roche Etanercept Production, Revenue, Price and Gross Margin (2014-2019)
- 7.6.4 Main Business and Markets Served
- 7.7 Cipla
- 7.7.1 Cipla Etanercept Production Sites and Area Served
- 7.7.2 Etanercept Product Introduction, Application and Specification
- 7.7.3 Cipla Etanercept Production, Revenue, Price and Gross Margin (2014-2019)
- 7.7.4 Main Business and Markets Served
- 7.8 Novartis
- 7.8.1 Novartis Etanercept Production Sites and Area Served
- 7.8.2 Etanercept Product Introduction, Application and Specification
- 7.8.3 Novartis Etanercept Production, Revenue, Price and Gross Margin (2014-2019)
- 7.8.4 Main Business and Markets Served
- 7.9 Celltrion
- 7.9.1 Celltrion Etanercept Production Sites and Area Served
- 7.9.2 Etanercept Product Introduction, Application and Specification
- 7.9.3 Celltrion Etanercept Production, Revenue, Price and Gross Margin (2014-2019)
- 7.9.4 Main Business and Markets Served
- 7.10 Immunex
- 7.10.1 Immunex Etanercept Production Sites and Area Served
- 7.10.2 Etanercept Product Introduction, Application and Specification
- 7.10.3 Immunex Etanercept Production, Revenue, Price and Gross Margin (2014-2019)
- 7.10.4 Main Business and Markets Served
8 Etanercept Manufacturing Cost Analysis
- 8.1 Etanercept Key Raw Materials Analysis
- 8.1.1 Key Raw Materials
- 8.1.2 Price Trend of Key Raw Materials
- 8.1.3 Key Suppliers of Raw Materials
- 8.2 Proportion of Manufacturing Cost Structure
- 8.3 Manufacturing Process Analysis of Etanercept
- 8.4 Etanercept Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
- 9.1 Marketing Channel
- 9.1.1 Direct Marketing
- 9.1.2 Indirect Marketing
- 9.2 Etanercept Distributors List
- 9.3 Etanercept Customers
10 Market Dynamics
- 10.1 Market Trends
- 10.2 Opportunities
- 10.3 Market Drivers
- 10.4 Challenges
- 10.5 Influence Factors
11 Global Etanercept Market Forecast
- 11.1 Global Etanercept Production, Revenue Forecast
- 11.1.1 Global Etanercept Production Growth Rate Forecast (2019-2025)
- 11.1.2 Global Etanercept Revenue and Growth Rate Forecast (2019-2025)
- 11.1.3 Global Etanercept Price and Trend Forecast (2019-2025)
- 11.2 Global Etanercept Production Forecast by Regions (2019-2025)
- 11.2.1 North America Etanercept Production, Revenue Forecast (2019-2025)
- 11.2.2 Europe Etanercept Production, Revenue Forecast (2019-2025)
- 11.2.3 China Etanercept Production, Revenue Forecast (2019-2025)
- 11.2.4 Japan Etanercept Production, Revenue Forecast (2019-2025)
- 11.3 Global Etanercept Consumption Forecast by Regions (2019-2025)
- 11.3.1 North America Etanercept Consumption Forecast (2019-2025)
- 11.3.2 Europe Etanercept Consumption Forecast (2019-2025)
- 11.3.3 China Etanercept Consumption Forecast (2019-2025)
- 11.3.4 Japan Etanercept Consumption Forecast (2019-2025)
- 11.4 Global Etanercept Production, Revenue and Price Forecast by Type (2019-2025)
- 11.5 Global Etanercept Consumption Forecast by Application (2019-2025)
12 Research Findings and Conclusion
13 Methodology and Data Source
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Etanercept are biopharmaceutical anti-Tumor Necrosis Factor (TNF) that treats autoimmune diseases such as arthritis and spondylitis.
The production of TNF in the body causes inflammation, pain, and damage to the bones and joints. Etanercept blocks the action of TNF and reduces the inflammation. It is prescribed to treat juvenile rheumatoid arthritis, rheumatoid arthritis, and psoriatic arthritis, plaque psoriasis, and ankylosing spondylitis.
The global Etanercept market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Etanercept volume and value at global level, regional level and company level. From a global perspective, this report represents overall Etanercept market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Pfizer
Takeda
Johnson & Johnson
GlaxoSmithKline
Samsung Bioepis
Roche
Cipla
Novartis
Celltrion
Immunex
Segment by Regions
North America
Europe
China
Japan
Segment by Type
Benepali
Enbrel
Others
Segment by Application
Arthritis
Psoriasis
Spondylitis